DK2276760T3 - Kondenserede ringforbindelser og anvendelse deraf - Google Patents

Kondenserede ringforbindelser og anvendelse deraf

Info

Publication number
DK2276760T3
DK2276760T3 DK09730930.6T DK09730930T DK2276760T3 DK 2276760 T3 DK2276760 T3 DK 2276760T3 DK 09730930 T DK09730930 T DK 09730930T DK 2276760 T3 DK2276760 T3 DK 2276760T3
Authority
DK
Denmark
Prior art keywords
condensed ring
ring connections
connections
condensed
ring
Prior art date
Application number
DK09730930.6T
Other languages
English (en)
Inventor
Nobuyuki Takakura
Tsuneo Yasuma
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of DK2276760T3 publication Critical patent/DK2276760T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK09730930.6T 2008-04-10 2009-04-09 Kondenserede ringforbindelser og anvendelse deraf DK2276760T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008102691 2008-04-10
PCT/JP2009/057625 WO2009125873A1 (en) 2008-04-10 2009-04-09 Fused ring compounds and use thereof

Publications (1)

Publication Number Publication Date
DK2276760T3 true DK2276760T3 (da) 2014-05-26

Family

ID=40671202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09730930.6T DK2276760T3 (da) 2008-04-10 2009-04-09 Kondenserede ringforbindelser og anvendelse deraf

Country Status (35)

Country Link
US (1) US8673942B2 (da)
EP (1) EP2276760B1 (da)
JP (1) JP5528348B2 (da)
KR (1) KR20110002472A (da)
CN (1) CN102056924B (da)
AR (1) AR073609A1 (da)
AU (1) AU2009234666B2 (da)
BR (1) BRPI0910912A2 (da)
CA (1) CA2720686A1 (da)
CO (1) CO6321240A2 (da)
CR (1) CR11730A (da)
CY (1) CY1115247T1 (da)
DK (1) DK2276760T3 (da)
DO (1) DOP2010000301A (da)
EA (1) EA019640B1 (da)
EC (1) ECSP10010602A (da)
ES (1) ES2476265T3 (da)
GE (1) GEP20135846B (da)
HK (1) HK1152932A1 (da)
HR (1) HRP20140588T1 (da)
IL (1) IL208463A (da)
MA (1) MA32283B1 (da)
ME (1) ME01887B (da)
MX (1) MX2010011138A (da)
MY (1) MY152475A (da)
NZ (1) NZ588562A (da)
PE (1) PE20100734A1 (da)
PL (1) PL2276760T3 (da)
PT (1) PT2276760E (da)
RS (1) RS53378B (da)
SI (1) SI2276760T1 (da)
UA (1) UA104422C2 (da)
UY (1) UY32131A (da)
WO (1) WO2009125873A1 (da)
ZA (1) ZA201007682B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8557805B2 (en) 2008-12-29 2013-10-15 Takeda Pharmaceutical Company Limited Fused ring compound and use thereof
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2014085486A2 (en) 2012-11-30 2014-06-05 Waters Technologies Corporation Methods and apparatus for the analysis of vitamin d metabolites
US9453038B2 (en) 2012-12-17 2016-09-27 Merck Sharp & Dohme Corp. Glucokinase activator compounds, compositions containing such compounds, and methods of treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505612A (ja) 1991-03-01 1993-08-19 ハー・ルンドベック・アクティーゼルスカブ 高血圧症及び末梢血管疾患の治療法
US6506901B2 (en) * 2000-07-17 2003-01-14 Wyeth Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
CN101103977A (zh) * 2002-06-05 2008-01-16 株式会社医药分子设计研究所 糖尿病治疗药
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
WO2006089397A1 (en) 2005-02-22 2006-08-31 Gemin X Biotechnologies Inc. Methods for treating arthritis using triheterocyclic compounds
US8957070B2 (en) * 2005-04-20 2015-02-17 Takeda Pharmaceutical Company Limited Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
US7799820B2 (en) * 2005-09-30 2010-09-21 Banyu Pharmaceutical Co., Ltd. 2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions
BRPI0717722A2 (pt) 2006-10-19 2013-10-29 Takeda Pharmaceutical Composto ou um sal do mesmo, pró-droga, ativador de glicoquinase, agente farmacêutico, métodos para ativar uma glicoquinase em um mamífero e para a profilaxia ou o tratamento de diabetes ou obesidade em um mamífero, e, uso do composto ou uma pró-droga do mesmo
JP5323834B2 (ja) * 2007-08-17 2013-10-23 エルジー・ライフ・サイエンシーズ・リミテッド 細胞壊死阻害剤としてのインドール化合物
KR101133772B1 (ko) * 2007-12-20 2012-04-24 주식회사 엘지생명과학 글루코키나아제 활성화제 및 이를 활성성분으로 함유하는 약제학적 조성물
US20100291533A1 (en) * 2008-01-04 2010-11-18 Soon Ha Kim Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
US8557805B2 (en) * 2008-12-29 2013-10-15 Takeda Pharmaceutical Company Limited Fused ring compound and use thereof

Also Published As

Publication number Publication date
ZA201007682B (en) 2011-12-28
IL208463A0 (en) 2010-12-30
BRPI0910912A2 (pt) 2015-08-11
MA32283B1 (fr) 2011-05-02
KR20110002472A (ko) 2011-01-07
WO2009125873A1 (en) 2009-10-15
ME01887B (me) 2014-12-20
GEP20135846B (en) 2013-06-10
CN102056924A (zh) 2011-05-11
EP2276760A1 (en) 2011-01-26
HRP20140588T1 (hr) 2014-08-01
PT2276760E (pt) 2014-05-28
ECSP10010602A (es) 2011-03-31
UA104422C2 (uk) 2014-02-10
CO6321240A2 (es) 2011-09-20
AR073609A1 (es) 2010-11-17
PL2276760T3 (pl) 2014-09-30
MX2010011138A (es) 2010-11-12
US8673942B2 (en) 2014-03-18
US20110098297A1 (en) 2011-04-28
CR11730A (es) 2010-12-08
PE20100734A1 (es) 2010-11-18
UY32131A (es) 2010-11-30
ES2476265T3 (es) 2014-07-14
HK1152932A1 (en) 2012-03-16
EP2276760B1 (en) 2014-04-09
JP2011516403A (ja) 2011-05-26
AU2009234666A1 (en) 2009-10-15
EA201071180A1 (ru) 2011-04-29
EA019640B1 (ru) 2014-05-30
MY152475A (en) 2014-10-15
CN102056924B (zh) 2014-05-21
DOP2010000301A (es) 2010-12-31
IL208463A (en) 2015-07-30
NZ588562A (en) 2012-07-27
CA2720686A1 (en) 2009-10-15
RS53378B (en) 2014-10-31
SI2276760T1 (sl) 2014-05-30
JP5528348B2 (ja) 2014-06-25
AU2009234666B2 (en) 2014-02-20
CY1115247T1 (el) 2017-01-04

Similar Documents

Publication Publication Date Title
DK2384327T3 (da) Forbindelse med kondenseret ring og anvendelse deraf.
SMT201600335B (it) Proteine leganti eterodimeri e loro usi
DK2276760T3 (da) Kondenserede ringforbindelser og anvendelse deraf
DK3292874T3 (da) Anti-mesothelin-immunkonjugater og anvendelser deraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
DK2349430T3 (da) KATETERISERINGANORDNING og -kit
DK3091034T3 (da) Anti-CD40-antistoffer og anvendelser deraf
BR112012004792A2 (pt) dispositivo cirúrgico e acessórios.
DK2137307T3 (da) Termostabile asparaginaser
DK2114993T3 (da) Vaccine
DK2552434T3 (da) Peptider og anvendelse deraf
DK2124829T3 (da) Omvendt skulderprotese
DK2086213T3 (da) Billedlæseapparat og billeddannelseapparat
DK2240203T3 (da) Alfa5-beta1-antistoffer og deres anvendelser
DK2805746T3 (da) Alkylamido-forbindelser og anvendelser deraf
DK2160336T3 (da) Forbindelsesmekanisme og fremgangsmåde
DK2424992T3 (da) Ny svampeprotease og anvendelse deraf
DK2642992T3 (da) Forbindelser og anvendelse deraf
DK2180951T3 (da) Gennemstrømningssensor og fremstillingsfremgangsmåde dertil
DK2274619T3 (da) Slimhindereceptor og anvendelser deraf
DK2252688T3 (da) Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser deraf